Search for: "KEY v. KEY" Results 1321 - 1340 of 29,382
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2012, 2:41 am by Marie Louise
  Highlights this week included: CAFC confirms patent eligibility of isolated DNA: AMP v. [read post]
2 Jan 2008, 12:55 pm
.'s cause at the Supreme Court in the key gun control case of D.C. v. [read post]
15 Jun 2011, 4:02 pm by Zachary Spilman
Monday’s CAAF daily journal shows an interesting grant and summary remand in U.S. v. [read post]
8 Sep 2015, 6:00 am by Carolyn Elefant
Facchetti – California Defamation Law – 3 Key Ways Technology Helps Me Serve Clients [read post]
25 Oct 2018, 5:48 pm by Robert Chesney, Steve Vladeck
Oh, hey, while we have your attention: Yes, there was another two-week extension in Doe v. [read post]
24 Jul 2020, 6:00 am by John J. O'Malley, Carey Kulp
The case centers on the validity of two key data transfer mechanisms: Standard Contractual Clauses (SCCs) and the EU-U.S. [read post]
23 Jan 2018, 9:49 am by Gerald Maatman, Jr.
Seyfarth Synopsis:  The fourth and final key trend from our 14th Annual Workplace Class Action Litigation Report involves rulings by the U.S. [read post]
16 Feb 2012, 11:43 pm by INFORRM
Prominent among the key players are Glenn Mulcaire, a private investigator hired by the News of the World and convicted of phone hacking in 2006, and Andy Coulson, Editor of the newspaper between 2003 and 2007. [read post]
16 Jan 2009, 6:40 pm
01/16/2009 By Brian Joyce Burlington - A key part of the sex crime bill that passed out of the Senate Judiciary Committee Friday aims to protect young victims from pretrial interrogation and pretrial depositions. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data… [read post]